Correlation Between GlaxoSmithKline PLC and Blue Chip
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Blue Chip at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Blue Chip into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Blue Chip Growth, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Blue Chip and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Blue Chip. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Blue Chip.
Diversification Opportunities for GlaxoSmithKline PLC and Blue Chip
-0.9 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Blue is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Blue Chip Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blue Chip Growth and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Blue Chip. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blue Chip Growth has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Blue Chip go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Blue Chip
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 3.41 times less return on investment than Blue Chip. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.13 times less risky than Blue Chip. It trades about 0.02 of its potential returns per unit of risk. Blue Chip Growth is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1,420 in Blue Chip Growth on August 31, 2024 and sell it today you would earn a total of 548.00 from holding Blue Chip Growth or generate 38.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Blue Chip Growth
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Blue Chip Growth |
GlaxoSmithKline PLC and Blue Chip Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Blue Chip
The main advantage of trading using opposite GlaxoSmithKline PLC and Blue Chip positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Blue Chip can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blue Chip will offset losses from the drop in Blue Chip's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Blue Chip vs. Eip Growth And | Blue Chip vs. Vanguard Growth And | Blue Chip vs. Rational Defensive Growth | Blue Chip vs. T Rowe Price |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |